Volver a la clasificación

The Ensign Group, Inc. (ENSG)

NEUTRAL
HealthcareMedical Care FacilitiesUnited States

Fundamental

68

Precio

$178.44

Capitalización Bursátil

$10.57B

Parte 1 · Cuánto vale la empresa

Resumen

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators. In addition, the company operates senior living units; and provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company operates healthcare facilities in Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Balance y Liquidez

Ingresos

$5.46B

Últimos 12 meses (hasta 30/6/2026)

Beneficio Neto

$379M

Últimos 12 meses (hasta 30/6/2026)

Flujo de Caja Libre

-

Patrimonio Neto Total

$2.23B

Pasivo Total

$3.23B

Ratio de Liquidez

1.21

Cobertura de Intereses

59.99

Deuda/EBITDA

4.25

Beneficio Por Acción

Ingresos y Beneficio Neto

Flujo de Caja Libre

Desglose de Ingresos

Estado histórico

Márgenes en el tiempo

La deuda en el tiempo

Cuánto pesa la deuda

Cuadro de crecimiento

Crecimiento — Ingresos

Estimación de Valor Justo

Valoración Justa

Valor Justo

$154.78

Precio Actual

$178.44

Margen de Seguridad

-15.3%

Rango de Valor Justo

$100.60 - $208.95

Métodos de Estimación

Analyst Target:$220.00
DCF:$93.59
PE-based:$139.36
Graham Growth:$202.81
EPV:$75.66
Consenso de Analistas:Compra Fuerte (10B / 2H / 0S)
Última Sorpresa de Resultados:+2.16%

Métricas de Valoración

Ratio P/E

28.11

ROE

15.4%

Ratio P/B

4.28

P/FCF

-

Margen Bruto

20.3%

ROIC

7.6%

Radar de Rentabilidad

Value Creation (Economic Moat)

ROIC

7.6%

WACC

6.8%

ROIC − WACC

+0.8 pp

ROIC is roughly in line with the cost of capital — the company is barely covering its capital cost.

Criterios de Análisis Fundamental

Superado (17)

  • EPS shows upward trend
  • EPS CAGR 8.64%
  • Price CAGR 24.07%
  • ROIC 7.6%
  • Debt/Equity ratio
  • Operating Margin 8.6%
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • ROE 16.5%
  • Revenue Growth 5Y 16.1%
  • Analyst Consensus 83% Buy
  • Earnings Quality (OCF/NI) 1.61
  • Share Dilution 1.2%
  • Piotroski F-Score 5/9

Fallido (7)

  • Gross Margin 20.3%
  • P/B Ratio 4.28
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Earnings Surprise avg 0.7%
  • PEG Ratio 2.02
  • Net Margin Trend 6.9% vs 7.0%

No disponible (4)

  • P/FCF NaN
  • Dividend Payout NaN%
  • Positive Free Cash Flow
  • CapEx intensity

Piotroski F-Score

5/9

Señales mixtas: algunas áreas requieren atención

score
criteria

Calidad de los Beneficios

1.61

Alta calidad: beneficios respaldados por efectivo

Dilución de Acciones

1.2%

El número de acciones es estable

Gobernanza

Equipo Directivo

NombreCargoEdad
Mr. Barry R. PortCEO & Chairman of the Board51
Mr. Spencer W. BurtonPresident & COO46
Ms. Suzanne D. Snapper CPACFO, Executive VP & Director51
Mr. Chad A. Keetch J.D.Chief Investment Officer, Executive VP & Secretary47
Ms. Beverly B. WittekindExecutive VP & General Counsel60
Kevin ReesePresident of Keystone Healthcare Inc-

Riesgo de Auditoría

7

Riesgo del Consejo

5

Riesgo de Compensación

7

Riesgo de Derechos del Accionista

2

Parte 2 · El precio y el momento de entrar

Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.

Latest News

Recent headlines for ENSG, sourced from Markets Gazette.

No recent news for ENSG.